David M Mott - Net Worth and Insider Trading
David M Mott Net Worth
The estimated net worth of David M Mott is at least $1.6 Billion dollars as of 2024-12-03. David M Mott is the Director, 10% Owner of Tesaro Inc and owns about 10,434,803 shares of Tesaro Inc (TSRO) stock worth over $782 Million. David M Mott is the 10% Owner of Rhythm Pharmaceuticals Inc and owns about 4,909,956 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $299 Million. David M Mott is also the 10% Owner of Mirum Pharmaceuticals Inc and owns about 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $193 Million. Besides these, David M Mott also holds Ra Pharmaceuticals Inc (RARX) , Adaptimmune Therapeutics PLC (ADAP) , AVEO Pharmaceuticals Inc (AVEO) , Millennial Media Inc (MM) , Trevi Therapeutics Inc (TRVI) , Ardelyx Inc (ARDX) , Surface Oncology Inc (SURF) , Imara Inc (IMRA) , Mersana Therapeutics Inc (MRSN) , Epizyme Inc (EPZM) , Novavax Inc (NVAX) , Regulus Therapeutics Inc (RGLS) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , Genocea Biosciences Inc (GNCAQ) , TRACON Pharmaceuticals Inc (TCON) , ARCA biopharma Inc (ABIO) , Appian Corp (APPN) . Details can be seen in David M Mott's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David M Mott has not made any transactions after 2024-11-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David M Mott
David M Mott Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David M Mott owns 52 companies in total, including Epizyme Inc (EPZM) , Adaptimmune Therapeutics PLC (ADAP) , and Novavax Inc (NVAX) among others .
Click here to see the complete history of David M Mott’s form 4 insider trades.
Insider Ownership Summary of David M Mott
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EPZM | Epizyme Inc | 2021-03-26 | director |
ADAP | Adaptimmune Therapeutics PLC | 2020-07-01 | director |
NVAX | Novavax Inc | 2021-09-23 | director |
2020-04-07 | director | ||
2024-11-13 | director | ||
2022-02-23 | director | ||
2020-02-06 | 10 percent owner | ||
2020-01-29 | 10 percent owner | ||
2019-05-07 | 10 percent owner | ||
2019-12-12 | 10 percent owner | ||
2019-11-06 | 10 percent owner | ||
2019-10-30 | 10 percent owner | ||
2019-09-12 | 10 percent owner | ||
2019-07-22 | 10 percent owner | ||
2019-06-24 | 10 percent owner | ||
2019-06-07 | director & 10 percent owner | ||
2019-05-09 | 10 percent owner | ||
2019-04-08 | 10 percent owner | ||
2019-01-22 | director & 10 percent owner | ||
2018-12-14 | 10 percent owner | ||
2018-12-07 | 10 percent owner | ||
2018-10-17 | 10 percent owner | ||
2018-10-17 | 10 percent owner | ||
2018-10-04 | 10 percent owner | ||
2018-05-01 | 10 percent owner | ||
2018-04-23 | 10 percent owner | ||
2018-03-27 | 10 percent owner | ||
2018-03-09 | 10 percent owner | ||
2018-02-26 | 10 percent owner | ||
2017-11-27 | 10 percent owner | ||
2015-09-30 | 10 percent owner | ||
2018-01-01 | 10 percent owner | ||
2017-11-20 | 10 percent owner | ||
2017-11-06 | 10 percent owner | ||
2017-10-10 | 10 percent owner | ||
2016-12-19 | 10 percent owner | ||
2016-09-21 | 10 percent owner | ||
2016-07-29 | 10 percent owner | ||
2015-10-14 | 10 percent owner | ||
2015-03-11 | 10 percent owner | ||
2015-01-22 | 10 percent owner | ||
2014-11-25 | 10 percent owner | ||
2014-10-08 | 10 percent owner | ||
2014-08-06 | 10 percent owner | ||
2014-04-02 | 10 percent owner | ||
2014-01-09 | 10 percent owner | ||
2011-11-21 | 10 percent owner | ||
2012-10-11 | 10 percent owner | ||
2012-10-29 | 10 percent owner | ||
2018-12-07 | 10 percent owner | ||
2020-03-11 | director | ||
2018-01-19 | 10 percent owner |
David M Mott Latest Holdings Summary
David M Mott currently owns a total of 23 stocks. Among these stocks, David M Mott owns 10,434,803 shares of Tesaro Inc (TSRO) as of March 6, 2018, with a value of $782 Million and a weighting of 48.98%. David M Mott owns 4,909,956 shares of Rhythm Pharmaceuticals Inc (RYTM) as of October 10, 2017, with a value of $299 Million and a weighting of 18.71%. David M Mott also owns 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) as of July 22, 2019, with a value of $193 Million and a weighting of 12.11%. The other 20 stocks Ra Pharmaceuticals Inc (RARX) , Adaptimmune Therapeutics PLC (ADAP) , AVEO Pharmaceuticals Inc (AVEO) , Millennial Media Inc (MM) , Trevi Therapeutics Inc (TRVI) , Ardelyx Inc (ARDX) , Surface Oncology Inc (SURF) , Imara Inc (IMRA) , Mersana Therapeutics Inc (MRSN) , Epizyme Inc (EPZM) , Novavax Inc (NVAX) , Regulus Therapeutics Inc (RGLS) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , Genocea Biosciences Inc (GNCAQ) , TRACON Pharmaceuticals Inc (TCON) , ARCA biopharma Inc (ABIO) , Appian Corp (APPN) have a combined weighting of 20.19% among all his current holdings.
Latest Holdings of David M Mott
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSRO | Tesaro Inc | 2018-03-06 | 10,434,803 | 74.96 | 782,192,833 |
RYTM | Rhythm Pharmaceuticals Inc | 2017-10-10 | 4,909,956 | 60.84 | 298,721,723 |
MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 4,186,243 | 46.21 | 193,446,289 |
RARX | Ra Pharmaceuticals Inc | 2016-10-31 | 3,490,073 | 47.99 | 167,488,603 |
ADAP | Adaptimmune Therapeutics PLC | 2020-01-24 | 102,478,668 | 0.72 | 74,112,573 |
AVEO | AVEO Pharmaceuticals Inc | 2019-04-08 | 2,524,387 | 15.00 | 37,865,805 |
MM | Millennial Media Inc | 2012-10-29 | 8,196,614 | 1.75 | 14,344,075 |
TRVI | Trevi Therapeutics Inc | 2019-05-09 | 4,438,562 | 2.86 | 12,694,287 |
ARDX | Ardelyx Inc | 2024-11-13 | 1,425,465 | 5.54 | 7,897,076 |
SURF | Surface Oncology Inc | 2018-04-23 | 3,312,877 | 1.07 | 3,544,778 |
IMRA | Imara Inc | 2022-02-23 | 229,224 | 6.32 | 1,448,696 |
MRSN | Mersana Therapeutics Inc | 2020-04-07 | 538,599 | 2.30 | 1,238,778 |
EPZM | Epizyme Inc | 2021-03-26 | 257,859 | 1.47 | 379,053 |
NVAX | Novavax Inc | 2021-09-23 | 40,000 | 8.77 | 350,800 |
RGLS | Regulus Therapeutics Inc | 2019-05-07 | 205,245 | 1.63 | 334,549 |
DERM | Dermira Inc | 2014-10-02 | 17,241 | 18.75 | 323,269 |
ILIU | Interleukin Genetics Inc | 2016-07-29 | 55,418,811 | 0.00 | 249,385 |
AKAOQ | Achaogen Inc | 2016-12-19 | 5,215,128 | 0.03 | 130,378 |
CLVSQ | Clovis Oncology Inc | 2011-11-21 | 3,419,671 | 0.02 | 51,295 |
GNCAQ | Genocea Biosciences Inc | 2019-06-24 | 7,225,676 | 0.00 | 723 |
TCON | TRACON Pharmaceuticals Inc | 2018-03-27 | 17,330 | 0.03 | 558 |
ABIO | ARCA biopharma Inc | 2018-02-26 | 0 | 25.50 | 0 |
APPN | Appian Corp | 2017-11-27 | 0 | 38.86 | 0 |
Holding Weightings of David M Mott
David M Mott Form 4 Trading Tracker
According to the SEC Form 4 filings, David M Mott has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the acquisition of 145,532 shares on March 6, 2018, which cost David M Mott around $8 Million.
According to the SEC Form 4 filings, David M Mott has made a total of 0 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years. The most-recent trade in Rhythm Pharmaceuticals Inc is the acquisition of 550,000 shares on October 10, 2017, which cost David M Mott around $9 Million.
According to the SEC Form 4 filings, David M Mott has made a total of 0 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 450,000 shares on July 22, 2019, which cost David M Mott around $7 Million.
More details on David M Mott's insider transactions can be found in the Insider Trading History of David M Mott table.Insider Trading History of David M Mott
- 1
David M Mott Trading Performance
GuruFocus tracks the stock performance after each of David M Mott's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David M Mott is 6.8%. GuruFocus also compares David M Mott's trading performance to market benchmark return within the same time period. The performance of stocks bought by David M Mott within 3 months outperforms 30 times out of 56 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David M Mott's insider trading performs compared to the benchmark.
Performance of David M Mott
David M Mott Ownership Network
David M Mott Owned Company Details
What does Epizyme Inc do?
Who are the key executives at Epizyme Inc?
David M Mott is the director of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .
Epizyme Inc (EPZM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Epizyme Inc Insider Transactions
David M Mott Mailing Address
Above is the net worth, insider trading, and ownership report for David M Mott. You might contact David M Mott via mailing address: 1119 St. Paul Street, Baltimore Md 21202.